Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUARTZ-CC: QL1706 + Chemotherapy as Neoadjuvant Therapy for Cervical Cancer
NCT07646301Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of iparomlimab + tuvonralimab in Cervical Cancer (CC), sponsored by Sun Yat-sen University. Started Jul 2026; status: recruiting.
02
Drugs
iparomlimab + tuvonralimab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07646301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07646301.